Search IPOs
Grey Market Premium · Mar 20 – Mar 24, 2026 · Issue Price ₹124
Speciality Medicines IPO GMP: ₹0.00 — 0.0% expected gain as of Mar 30, 2026
The Speciality Medicines IPO Grey Market Premium (GMP) is currently trading at ₹0.00 in the unofficial grey market. Based on this, the expected listing price is ₹124.00, implying a +0.0% gain over the issue price of ₹124. GMP reflects pre-listing demand from grey market participants and is a widely tracked sentiment indicator among IPO investors.
Grey market premium over time (₹)
Latest 14 data points, most recent first
| Date / Time | GMP (₹) | Exp. Listing | Exp. Gain |
|---|---|---|---|
| Mar 30, 2026 2:40 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 29, 2026 11:22 am | +₹0.00 | ₹124.00 | +0.0% |
| Mar 28, 2026 1:23 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 27, 2026 12:06 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 26, 2026 12:14 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 25, 2026 2:27 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 24, 2026 1:04 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 23, 2026 1:35 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 22, 2026 2:44 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 21, 2026 3:52 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 20, 2026 1:58 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 19, 2026 2:28 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 18, 2026 3:42 pm | +₹0.00 | ₹124.00 | +0.0% |
| Mar 17, 2026 3:19 pm | +₹0.00 | ₹124.00 | +0.0% |
The Speciality Medicines IPO GMP (Grey Market Premium) is the unofficial pre-listing price at which shares trade in informal markets before the IPO is listed on the stock exchange. Currently, the Speciality Medicines IPO GMP stands at ₹0.00, implying an expected listing price of ₹124.00.
GMP = Expected Listing Price − Issue Price. If the issue price of Speciality Medicines IPO is ₹124 and the expected listing is ₹124.00, then GMP = ₹0.00. The expected gain percentage is calculated as (GMP ÷ Issue Price) × 100. For Speciality Medicines IPO, that is 0.0%.
GMP is not regulated by SEBI and reflects informal market activity. It can fluctuate significantly day-to-day and should not be the sole basis for investment decisions. Many IPOs with high GMP have listed below expectations, and vice versa. Always refer to subscription data, financials, and the DRHP before investing.
We classify GMP signals as: Hot (expected gain ≥30%), Warm (10–30%), Neutral (0–10%), and Weak (negative GMP). Speciality Medicines IPO is currently classified as Neutral.
The current Grey Market Premium for Speciality Medicines IPO is ₹0.00 as of Mar 30, 2026. Expected listing price: ₹124.00, expected gain: 0.0%. GMP data is updated periodically from grey market sources.
A GMP of ₹0.00 means that in the unofficial grey market, Speciality Medicines IPO shares are trading at ₹0.00 above the issue price. With an issue price of ₹124, this implies an expected listing at ₹124.00 (0.0% gain). GMP is purely indicative and actual listing price depends on market conditions.
GMP is an unofficial, unregulated indicator from the informal grey market. It reflects speculative pre-listing demand but can be manipulated or change rapidly. Use it as one data point alongside official subscription data, company financials, and valuation metrics. SEBI does not regulate grey market trading.
Kostak rate data for Speciality Medicines IPO will be available once reported from grey market sources. Kostak represents the per-application premium in informal markets.
Speciality Medicines IPO is expected to list on March 30, 2026 on BSE SME platform. The GMP on listing day is a strong short-term indicator of opening price.
GMP is unofficial and unregulated. Past GMP accuracy varies. Use alongside subscription data and fundamentals.